Scientific Library of Tomsk State University

   E-catalog        

Normal view MARC view

Aptamer-conjugated superparamagnetic ferroarabinogalactan nanoparticles for targeted magnetodynamic therapy of cancer O. S. Kolovskaya, T. N. Zamay, G. S. Zamay [et al.]

Contributor(s): Zamay, Tatiana N | Zamay, Galina S | Babkin, Vasily A | Medvedeva, Elena N | Neverova, Nadezhda A | Kirichenko, Andrey K | Zamay, Sergey S | Lapin, Ivan N | Morozov, Evgeny V | Kolovskaya, Olga S | Sokolov, Alexey E | Narodov, Andrey A | Fedorov, Dmitri G | Tomilin, Felix N | Zabluda, Vladimir N | Svetlichnyi, Valerii AMaterial type: ArticleArticleSubject(s): аптамеры | арабиногалактан | ферроарабиногалактан | магнитодинамическая терапия | магнитно-резонансная томография | суперпарамагнитные наночастицы | таргетная терапия | онкологияGenre/Form: статьи в журналах Online resources: Click here to access online In: Cancers Vol. 12, № 1. P. 216 (1-17)Abstract: Nanotechnologies involving physical methods of tumor destruction using functional oligonucleotides are promising for targeted cancer therapy. Our study presents magnetodynamic therapy for selective elimination of tumor cells in vivo using DNA aptamer-functionalized magnetic nanoparticles exposed to a low frequency alternating magnetic field. We developed an enhanced targeting approach of cancer cells with aptamers and arabinogalactan. Aptamers to fibronectin (AS-14) and heat shock cognate 71 kDa protein (AS-42) facilitated the delivery of the nanoparticles to Ehrlich carcinoma cells, and arabinogalactan (AG) promoted internalization through asialoglycoprotein receptors. Specific delivery of the aptamer-modified FeAG nanoparticles to the tumor site was confirmed by magnetic resonance imaging (MRI). After the following treatment with a low frequency alternating magnetic field, AS-FeAG caused cancer cell death in vitro and tumor reduction in vivo. Histological analyses showed mechanical disruption of tumor tissues, total necrosis, cell lysis, and disruption of the extracellular matrix. The enhanced targeted magnetic theranostics with the aptamer conjugated superparamagnetic ferroarabinogalactans opens up a new venue for making biocompatible contrasting agents for MRI imaging and performing non-invasive anti-cancer therapies with a deep penetrated magnetic field.
Tags from this library: No tags from this library for this title. Log in to add tags.
No physical items for this record

Библиогр.: 46 назв.

Nanotechnologies involving physical methods of tumor destruction using functional oligonucleotides are promising for targeted cancer therapy. Our study presents magnetodynamic therapy for selective elimination of tumor cells in vivo using DNA aptamer-functionalized magnetic nanoparticles exposed to a low frequency alternating magnetic field. We developed an enhanced targeting approach of cancer cells with aptamers and arabinogalactan. Aptamers to fibronectin (AS-14) and heat shock cognate 71 kDa protein (AS-42) facilitated the delivery of the nanoparticles to Ehrlich carcinoma cells, and arabinogalactan (AG) promoted internalization through asialoglycoprotein receptors. Specific delivery of the aptamer-modified FeAG nanoparticles to the tumor site was confirmed by magnetic resonance imaging (MRI). After the following treatment with a low frequency alternating magnetic field, AS-FeAG caused cancer cell death in vitro and tumor reduction in vivo. Histological analyses showed mechanical disruption of tumor tissues, total necrosis, cell lysis, and disruption of the extracellular matrix. The enhanced targeted magnetic theranostics with the aptamer conjugated superparamagnetic ferroarabinogalactans opens up a new venue for making biocompatible contrasting agents for MRI imaging and performing non-invasive anti-cancer therapies with a deep penetrated magnetic field.

There are no comments on this title.

to post a comment.
Share